A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?

A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?

Abstract The burden of liver-related morbidity remains high among HIV-infected patients, despite advances in the treatment of HIV and viral hepatitis. Especially, the impact of non-alcoholic fatty liver disease (NAFLD) is significant with a prevalence of up to 50%. The pathogenesis of NAFLD and the...

Full description

Bibliographic Details
Main Authors: Berend J. van Welzen, Tania Mudrikova, Ayman El Idrissi, Andy I. M. Hoepelman, Joop E. Arends
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-01-01
Series:Infectious Diseases and Therapy
Subjects:
Antiretroviral therapy
Fibrosis
HIV
NASH
Non-alcohol fatty liver disease
Online Access:http://link.springer.com/article/10.1007/s40121-018-0229-7

Internet

http://link.springer.com/article/10.1007/s40121-018-0229-7

Similar Items